미국의 동물용 인공수정 시장 규모, 점유율, 동향 분석 리포트 : 솔루션별, 동물 유형별, 유통 채널별, 부문별 예측(2025-2030년)

U.S. Veterinary Artificial Insemination Market Growth & Trends:

The U.S. veterinary artificial insemination market size is expected to reach USD 2.77 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. ?The market is experiencing robust growth, driven by several key factors reshaping the landscape of animal breeding. Technological advancements in semen processing, such as sexed semen and genomic selection, have enabled producers to make more informed breeding decisions, leading to improved genetic traits in livestock. For instance, companies like STgenetics offer sex-sorted semen with high purity rates, allowing dairy farmers to increase the proportion of female calves, which are more valuable for milk production. Additionally, integrating AI-powered analytics in breeding operations enhances efficiency and reduces costs, making AI more accessible to producers.

Growing emphasis on precision breeding and sustainability is contributing to market growth. Producers are increasingly adopting AI to enhance reproductive efficiency, reduce the spread of diseases, and improve overall herd health. The rise of mobile veterinary AI services is also noteworthy, as they provide on-site breeding solutions, particularly in rural areas, thereby increasing accessibility to advanced reproductive technologies. For example, CVM Ranch at Oklahoma State University is a horse and cattle reproductive research hub, offering hands-on learning and conducting studies to improve livestock reproductive health.

Opportunities in the market are abundant, particularly in underserved regions where access to advanced breeding technologies is limited. The expansion of mobile AI services and the establishment of veterinary AI service stations can bridge this gap, providing high-quality breeding solutions to a broader range of producers. Moreover, the increasing focus on sustainable and efficient livestock production presents avenues for innovation in breeding practices, such as selecting traits that improve feed conversion and adaptability to varying climates. Companies like Select Sires are leading the way with initiatives like the Elite Sexed Fertility product line, which identifies sires with superior fertility and sex-sorted semen, catering to the evolving needs of the industry.

The swine industry is increasingly adopting AI to enhance reproductive efficiency and genetic quality, driven by rising pork consumption and advancements in reproductive technologies. Companies like Shipley Swine Genetics are leading the way by offering high-quality semen and comprehensive breeding programs. In the equine sector, research institutions are exploring innovative techniques, such as comparing stallion sperm mixing methods, to improve semen quality and longevity. These developments present significant growth prospects for the veterinary AI market as producers seek to leverage advanced reproductive technologies to meet the growing demand for high-quality animal products.

U.S. Veterinary Artificial Insemination Market Report Highlights:

• Based on solutions, the services segment dominated the market with a share of 41.87% in 2024. On the other hand, the semen segment is anticipated to grow the fastest at a rate of 6.4% in the coming years.
• Artificial insemination (AI) offers a safe and regulated environment for breeding, lowering the possibility of mishaps or injuries that could happen during natural mating. Furthermore, AI gives breeders more control over the breeding process, ensuring that mating takes place under the best possible circumstances and raising the likelihood of viable pregnancies.
• Based on distribution channel, the private segment accounted for the largest revenue share of the market in 2024 and is also projected to grow at the fastest CAGR over the forecast period.
• In 2024, the bovine segment accounted for the largest share of the market by animal type. The swine segment is estimated to grow at the fastest CAGR of 7.4%.
• As the U.S. population continues to grow, there is an increasing demand for animal protein, including meat, milk, and eggs. This drives the need for efficient breeding practices to optimize livestock production, which includes the use of artificial insemination to improve genetics and reproductive efficiency.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. U.S. Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Veterinary Artificial Insemination Industry Outlook

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing demand for meat, dairy, and dairy products
    • 3.2.1.2. Increasing need for sustainable food production
    • 3.2.1.3. Advancements in animal reproduction technology
    • 3.2.1.4. Supportive Initiatives
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of awareness
    • 3.2.2.2. Limited access to supplies & skilled labor in certain countries
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Veterinary Artificial Insemination Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological & Environmental landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Regulatory Landscape
  • 3.3.5. Estimated Animal Population, by Key Species, 2024
  • 3.3.6. COVID-19 Impact Analysis

Chapter 4. U.S. Veterinary Artificial Insemination Market: Solutions Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Veterinary Artificial Insemination Market: Solutions Movement Analysis
• 4.3. U.S. Veterinary Artificial Insemination Market Size & Trend Analysis, by Solutions, 2018 to 2030 (USD Million)
• 4.4. Equipment & Consumables
  • 4.4.1. Equipment & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Semen
  • 4.5.1. Normal
  • 4.5.2. Normal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Sexed
  • 4.5.4. Sexed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Veterinary Artificial Insemination Market: Animal Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Veterinary Artificial Insemination Market: Animal Type Movement Analysis
• 5.3. U.S. Veterinary Artificial Insemination Market Size & Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
  • 5.3.1. Bovine
    • 5.3.1.1. Bovine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Swine
    • 5.3.2.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Ovine & Caprine
    • 5.3.3.1. Ovine & Caprine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. Equine
    • 5.3.4.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.5. Other Animals
    • 5.3.5.1. Other Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Veterinary Artificial Insemination Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Veterinary Artificial Insemination Market: Distribution Channel Movement Analysis
• 6.3. U.S. Veterinary Artificial Insemination Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 6.4. Private
  • 6.4.1. Private Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Public
  • 6.5.1. Public Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Company Market Position Analysis/ Heap Map Analysis
• 7.3. Company Profiles
  • 7.3.1. Genus
    • 7.3.1.1. Participant's Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Product Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. URUS Group LP
    • 7.3.2.1. Participant's Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Product Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. CRV
    • 7.3.3.1. Participant's Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Product Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. Semex
    • 7.3.4.1. Participant's Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Product Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. IMV Technologies
    • 7.3.5.1. Participant's Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Product Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Select Sires Inc.
    • 7.3.6.1. Participant's Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Product Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Swine Genetics International
    • 7.3.7.1. Participant's Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Product Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Shipley Swine Genetics
    • 7.3.8.1. Participant's Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Product Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Stallion AI Services Ltd
    • 7.3.9.1. Participant's Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Product Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. STgenetics
    • 7.3.10.1. Participant's Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Product Benchmarking
    • 7.3.10.4. Strategic Initiatives
• 7.4. Strategy Mapping
  • 7.4.1. Mergers & Acquisitions
  • 7.4.2. Partnerships & Collaborations
  • 7.4.3. Others
• 7.5. List of Other Key Manufacturers
• 7.6. List of Distributors by Region